ReachMD

Be part of the knowledge.™

Clinical Pharmacology

793

LikeLikedUnlike

Episodes 16-30 of 243

- Ajay K. Gopal, MD
  Peer
0
$Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma$ $Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma$
CME/CE
Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma
Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma
0.25 credits
- Linda Bernstein, Pharm.D.
  Peer
6
The Drug Report
Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
- Ruben A. Mesa, MD, FACP
  Peer
5
CME/CE
Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis
Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis
0.50 credits
- Ruben A. Mesa, MD, FACP
  Peer
5
CME/CE
Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis
Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis
0.50 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
5
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
1.00 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
7
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
0.50 credits
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Douglas Drossman, MD
  Peer
2
GI Insights
How Neuromodulators Can Treat Functional GI Disorders
How Neuromodulators Can Treat Functional GI Disorders
- Keith S. Kaye, MD, MPH
  Peer
- Marin H. Kollef, MD, FACP, FCCP
  Peer
- Douglas N. Fish, PharmD
  Peer
7
CME/CE
Critical Updates in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Critical Updates in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
0.25 credits
- Abdullah Abdussalam, MD
  Peer
14
AudioAbstracts
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
- Mario R. Nacinovich, Jr., MSc
  Peer
- David Fajgenbaum, MD
  Peer
9
COVID-19: On The Frontlines
Research Efforts in the Race to Find a Cure for COVID-19
Research Efforts in the Race to Find a Cure for COVID-19
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
5
COVID-19: On The Frontlines
Investigating the Circulation of Counterfeit COVID-19 Medications
Investigating the Circulation of Counterfeit COVID-19 Medications
- Matt Birnholz, MD
  Peer
- Frank Scott, MD
  Peer
1
Crohn’s & Colitis Foundation Perspectives
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
- Linda Bernstein, Pharm.D.
  Peer
2
The Drug Report
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
- John J. Russell, MD
  Peer
12
COVID-19: On The Frontlines
Off-Label Medicines in Fighting COVID-19 & Through the Years
Off-Label Medicines in Fighting COVID-19 & Through the Years
- Linda Bernstein, Pharm.D.
  Peer
3
The Drug Report
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP

Programs 5/9/21

Segment Chapters

Playlist:

Recommended